Viatris to Acquire Pacira BioSciences in $1.65 Billion Deal

Key Facts

1Viatris announced the acquisition of Pacira BioSciences in a deal valued at approximately $1.65 billion.

Viatris announced the acquisition of Pacira BioSciences in a deal valued at approximately $1.65 billion. Investing.com reported that the companies have reached a definitive agreement for the transaction.

The acquisition is a strategic move designed to expand Viatris's portfolio within the healthcare and biosciences sector. This consolidation reflects a broader trend of growth-focused acquisitions within the pharmaceutical industry.